Avoid common mistakes on your manuscript.
Correction: Neurol Ther (2023) 12:1867–1881 https://doi.org/10.1007/s40120-023-00535-z
In this article Ref. [25] was incorrect and should have been as given below.
Reference
Monreal E, Fernández-Velasco J, García-Sánchez MI, et al. Association of serum neurofilament light chain levels at disease onset with disability worsening in patients with a first demyelinating multiple sclerosis event not treated with high-efficacy drugs. JAMA Neurol. 2023 Apr 1;80(4):397–403. https://doi.org/10.1001/jamaneurol.2023.0010. PMID: 36848127; PMCID: PMC9972238.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Ghezzi, A., Neuteboom, R.F. Correction: Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment. Neurol Ther 13, 931 (2024). https://doi.org/10.1007/s40120-024-00598-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40120-024-00598-6